Mitchell Cancer Institute | Strategic Alliance Partners

Latest from Mitchell Cancer Institute


Novel Agents Needed in MPNs Paradigm to Improve Outcomes

September 03, 2020

Omar Alkharabsheh, MD, discusses the growing treatment options for patients with myeloproliferative neoplasms, including polycythemia vera, essential thrombocythemia and myelofibrosis, and how available agents have not induced a biological change or shown improvement in disease outcomes.

With the Aid of an Upgraded Acuity Tool, Fewer Patients Slip Through the Cracks

December 23, 2017

A caseload management tool developed at the Mitchell Cancer Institute at the University of South Alabama offers a comprehensive portrait of a patient's condition that helps oncology nurse navigators to allocate their time and resources efficiently and enables managers to optimize patient care by assigning appropriate caseloads.

x